Loading interactive trading data…

FATE (Fate Therapeutics, Inc.): Congressional Trading Activity

Who traded FATE?

FATE (Fate Therapeutics, Inc.) appears in 1 STOCK Act disclosures from 1 filer (0 purchases, 1 sales), most recently Daniel Goldman on Jan 31, 2023.

Disclosed trades

FilerTrade dateTypeAmount
Daniel GoldmanJan 31, 2023Sale (Full)$1,001 - $15,000

Congress Trading Monitor home